Abingdon Life Sciences

Abingdon Health is a leading international lateral flow diagnostics company that provides comprehensive contract development and manufacturing (CDMO) services. Headquartered in York, UK, with a significant presence in the US, the company specializes in taking rapid diagnostic tests from initial concept through to large-scale manufacturing across clinical, animal health, plant health, and environmental sectors. Abingdon Health is publicly traded on the London Stock Exchange (AIM: ABDX) and offers a full 'idea to commercial success' service, including regulatory and quality assurance support through its subsidiaries Compliance Solutions and IVDeology. Its product portfolio includes the SaliStick saliva-based pregnancy test and the AbC-19 COVID-19 antibody test, alongside a robust platform for nucleic acid detection (PCRD).